Recent studies have shown that two recurrent translocations, t(4;14)(p16;q32) and t(11;14)(q13;q32), define distinct entities with different prognosis in multiple myeloma (MM). We addressed the issue of whether these illegitimate IGH rearrangements could contribute to the morphological heterogeneity of the malignant plasma cells (PC). Bone marrow aspirates of 178 untreated MM cases with successful molecular cytogenetics analysis using fluorescence in situ hybridization were reviewed. PC of 25/48 (52%) patients with t(11;14) exhibited a lymphoplasmacytoid morphology. Moreover, 25/27 (93%) of the cases with this morphological profile bore the t(11;14). In addition, both cytogenetics and morphological subtypes shared higher incidence of nonsecretory MM. In contrast, 17 out of 28 cases (61%) with t(4;14) exhibited PC with diffuse chromatin pattern. Interestingly, both t(4;14) translocation and immature morphology correlated with higher incidence of high tumor mass and chromosome 13 abnormality. In conclusion, our results suggest that a particular morphology can be the signature of chromosomal abnormalities in MM.
Introduction
Multiple myeloma (MM) is a plasma cell (PC) malignancy with variable survival depending on parameters, related mainly to tumor mass, kinetics, morphology and genetics. Indeed, both immature and plasmablastic subtypes identified patients with a poor prognosis, while those with a mature morphology experienced better survival. [1] [2] [3] [4] However, morphological definitions differ between studies, probably because of arbitrary criteria. Recently, some chromosomal abnormalities have been shown to be powerful prognostic factors, including the chromosome 13 abnormality (C13A) and recurrent 14q32 translocations. Thus, both C13A and t(4;14) are associated with a poor prognosis, whereas patients with t(11;14) displayed a longer survival. 5, 6 Hence, they might represent distinct entities. 6, 7 In this study, we addressed the issue of whether these illegitimate IGH rearrangements could contribute to the morphological heterogeneity of MM.
Materials and methods

Patients
We studied 178 consecutive newly diagnosed and previously untreated MM patients with successful molecular cytogenetic analysis by fluorescence in situ hybridization (FISH) and a bone marrow aspirate containing at least 10% PC referred at our institution from November 1997 to July 2002. A total of 28 cases with insufficient bone marrow infiltrate (less than 10% PC) or poor smear quality have been excluded. The median age was 66 years (range 32-91 years). 
Morphological studies
Two observers (RG, FA) independently reviewed the bone marrow aspirates without knowing cytogenetic results. At least 100 PC per slide were studied by each of them. Nucleus (49 mm) and nucleolus (42 mm) were considered as large and chromatin pattern was defined as dense clumped, dispersed heterogeneous or diffuse homogeneous according to Greipp et al. 1 Reduced cytoplasm was considered when nuclearcytoplasmic (N/C) ratio exceeded 0.6 according to Goasguen et al. 3 Definitions of mature PC (small nucleus with clumped chromatin), intermediate PC (large nucleus or nucleolus or dispersed chromatin), immature PC (diffuse chromatin) and plasmablasts (same as immature PC but with reduced cytoplasm) were derived from Greipp et al. 1, 4 Mature PC with reduced cytoplasm were distinguished and termed lymphoplasmacytoid PC (LP-PC), according to Hoyer et al. 8 Concordance between observers was reached in 152 cases (85%) and in all 178 cases after simultaneous re-evaluation of the discordant slides on a multihead microscope. In 18 patients, plasmablasts (X2% of all PC) were initially observed by at least one of the observers. A final agreement was obtained in 14 of them (78%) after simultaneous re-evaluation of the discordant slides. In all of these cases, including the discordant cases, a significant proportion of immature PC (X12%) was always associated to the plasmablasts. The proportion of each PC category (expressed as a percentage of all myeloma cells) was the mean of both counting in case of initial concordance or the consensus result obtained after the second examination in case of discordance between the observers.
FISH analysis
All the patients were analyzed by FISH, as previously reported. 7 In brief, malignant PC were purified using anti-CD138-coated magnetic beads (Miltenyi Biotech, Paris, France), fixed and labeled with probes specifically detecting the following abnormalities: del(13), t(4;14) and t(11;14) and other 14q32 rearrangements. C13A and t(14q32) were found in 83 and 132 patients, including the t(4;14) and t(11;14) in 28 and 48 of them, respectively.
Statistical analysis
Comparison of morphological features, t(14q32) subtypes and clinical and laboratory variables were performed with the w 2 test and Fisher's exact test.
Results
Morphological features of MM cells are strongly correlated with t(14q32) subtypes
The cutoff values of each PC category, that is, LP-PC (X25% PC), intermediate PC (X20% PC) and immature PC (X12%) were determined as the most discriminant percentages between each t(14q32) subtypes, as shown in Figure 1 . That of plasmablasts was arbitrarily chosen (X2%), according to Greipp et al. 1 Myeloma cells were composed of a majority of mature PC in 39/48 (81%) patients with t(11;14), including LP-PC (X25% PC) (Figure 2a ) in 26 (54%) of them. On the other hand, a similar proportion of LP-PC was observed in only 10/130 (8%) other patients (Po0.0001), including 1/28 (4%) with t(4;14) and 9/102 (9%) without both t(11;14) and t(4;14). In contrast, 17/28 (61%) patients with t(4;14) exhibited more than 11% PC with a diffuse chromatin pattern, including at least 2% plasmablasts in eight (29%) of them ( Figure 2b ). These immature morphology features, that is, diffuse chromatin pattern and plasmablasts, were absent in all the t(11;14) MM cases and were present in only 8/102 (8%) and 6/ 102 (6%) of the other patients, respectively (Po0.0001, 0.002). In these latter cases without t(11;14) and t(4;14), at least 20% of myeloma cells exhibited an intermediate morphology in 81/102 (79%) of them.
Given the morphological difference between 14q32 translocation subgroups described above, we defined four distinct MM morphological profiles (Table 1, Figure 2 ). As shown in Table 2 , patients with t(11;14) exhibited a type I (mature) and type II (lymphoplasmocytoid) profile more frequently than those without this translocation (29 and 52 vs 11 and 2%, Po0.01 and 0.0001, respectively). Moreover, the latter profile was highly predictive of the t(11;14) since 25/27 (93%) of the cases with type II exhibited this translocation (Figure 1a Morphology and recurrent translocations in MM R Garand et al both t(11;14) and t(4;14) vs only 20/76 (26%) of those with one of these translocations (Po0.0001). In contrast, 61% of the patients bearing a t(4;14) showed a type IV (immature) profile (Figure 1b) vs only 8/150 (5%) cases without this translocation (Po0.0001). Interestingly, the plasmablastic subtype of type IV predicted the t(4;14) translocation similarly (8/14 (57%)) as compare to type IV with less than 2% plasmablasts (9/11 (82%)).
Some clinical and laboratory variables are correlated with both morphological and t(14q32) subtypes.
The NS form was significantly more frequent in both lymphoplasmacytoid type II (4/27 (15%)) and t(11;14) MM subgroups (6/47 (13%)) than in the other morphological (4/151 (2.6%)) and cytogenetic (2/130 (1.4%)) subtypes (Po0.02, 0.005, respectively).
On the other hand, patients with immature type IV (whatever the presence or absence of plasmablasts) and those with t(4;14) exhibited similar higher incidence of clinical stage III (21/25 (84%), 24/28 (86%)) than cases without immature morphology (85/142 (56%), Po0.01) and without t(4;14) (82/150 (55%), Po0.004). Also, C13As were similarly more frequent in both type IV (16/25 (60%)) and t(4;14) subgroups (21/28 (75%)), in comparison with cases with other morphological profiles (61/153 (40%), Po0.04) and those without t(4;14) (56/150 (37%), Po0.002). IgA isotype and b 2 M level 43 mg/l were significantly more frequent in the t(4;14) group (14/28 (50%), 22/27 (81%)) than in the other patients (35/150 (23%) and 73/144 (51%), Po0.01, 0.01, respectively). There was a trend for similar results in the type IV subgroup (IgA isotype: 40%, b 2 M level 43 mg/l: 72%), but the difference with other morphological subgroups did not reach statistical significance.
Discussion
Here, we show that two recurrent translocations, t(4;14) and t(11;14), which account for up to 50% of 14q32 rearrangements in MM, 6, 7 are strongly associated with particular morphology. Thus, the t(11;14) translocation was associated with MM composed of small mature PC with reduced cytoplasm. This lymphoplasmocytoid subtype accounted for half of t(11;14) MM in our study and was predictive of the translocation in 93%. Interestingly, this subtype has been observed in 42% of patients with t(11;14) on karyotype (most at relapse) in the series by Hoyer et al, 8 that is a unique previously published study trying to relate PC morphology to t(11;14) genotype. The morphology of myeloma cells harboring the t(4;14) translocation was strikingly different with 61% of our t(4;14) MM cases exhibiting a significant proportion of immature PC with a fine chromatin pattern. In some, but not all of them, a significant amount of plasmablasts, as defined by Greipp et al, 1, 4 was present. The predictive value of this immature myeloma profile for the t(4;14) reached 68%, but was not influenced by the presence or absence of plasmablasts.
The relationship between morphology and cytogenetics is further supported by other observations. In our study, mature lymphoplasmacytoid and t(11;14) MM subtypes shared similar higher incidence of NS form. Also, other common features have been reported in both MM subsets, that is, lower secreting capacity, CD20 expression and association with IgM isotype. [9] [10] [11] On the other hand, both immature morphology and t(4;14) correlated with some adverse prognostic factors, including high tumor mass and C13A, whatever the presence or absence of plasmablasts. In addition, higher serum level of sIL6-R, b 2 M and PC proliferative indices have been reported in both t(4;14) and plasmablastic MM subtypes. 4, 6, 7 In conclusion, recurrent translocations are associated with a particular morphology in MM, that is, t(11;14)/lymphoplasmacytoid and t(4;14)/immature subtypes. Hence, these findings support the concept that MM is composed of distinct subsets genetically driven, as human leukemias. Table 1 ).The first parentheses (after the number of cases) give the percentage of morphological subclasses in each 14q32 rearrangement subtype. The second parentheses give the percentage of 14q32 rearrangement subtypes in each morphological subclass (predictive ability). 'n': number of cases. a Absence of t(11;14) and t(4;14).
